Literature DB >> 17418460

The use of vaccination to combat multiple introductions of Notifiable Avian Influenza viruses of the H5 and H7 subtypes between 2000 and 2006 in Italy.

Ilaria Capua1, Stefano Marangon.   

Abstract

Since 1999, Italy has been challenged by several epidemics of Notifiable Avian Influenza (NAI) of the H5 and H7 subtypes, occurring in the densely populated poultry areas of northern part of the country. Vaccination with a conventional vaccine containing a seed strain with a different neuraminidase subtype to the field virus was used to complement biosecurity and restriction measures as part of an overall eradication strategy. This vaccination technique, known as the "DIVA-Differentiating Infected from Vaccinated Animals" system, enabled, the identification of field exposed flocks and ultimately the eradication of H7N1, H7N3 and H5N2 infections. A bivalent H5/H7 prophylactic vaccination programme of defined poultry populations was introduced subsequently to increase their resistance to field infection. Retrospective analysis of the outbreaks identified important reservoir species such as quail, and demonstrated clearly the higher susceptibility of turkeys to infection. Data generated during 6 years of experience with vaccination against Avian Influenza (AI) indicate that it is a useful tool to limit secondary spread and possibly prevent the introduction of AI viruses in a susceptible population. The Italian AI control programme including vaccination was managed in a flexible manner and enabled the continuation of international trade. It is imperative that if vaccination is to be used to combat the current H5N1 epidemic it is used in conjunction with other measures and under official supervision. An extraordinary effort is required from international organisations to accredit control strategies so that harmonised and validated programs can be implemented. Transparency and sharing of field results from countries that are practising such programmes is crucial to the progressive control and ultimately the eradication of NAI infections in the animal reservoir.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17418460     DOI: 10.1016/j.vaccine.2007.01.113

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

Review 1.  Discovering Invisible Truths.

Authors:  Ilaria Capua
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

2.  Antigenic and genetic evolution of low-pathogenicity avian influenza viruses of subtype H7N3 following heterologous vaccination.

Authors:  Maria Serena Beato; Yifei Xu; Li-Ping Long; Ilaria Capua; Xiu-Feng Wan
Journal:  Clin Vaccine Immunol       Date:  2014-02-19

3.  Evaluating the control of HPAIV H5N1 in Vietnam: virus transmission within infected flocks reported before and after vaccination.

Authors:  Ricardo J Soares Magalhães; Dirk U Pfeiffer; Joachim Otte
Journal:  BMC Vet Res       Date:  2010-06-05       Impact factor: 2.741

4.  Evaluation of a competitive ELISA for antibody detection against avian influenza virus.

Authors:  Dae Sub Song; Youn Jeong Lee; Ok Mi Jeong; Yong Joo Kim; Chan Hee Park; Jung Eun Yoo; Woo Jin Jeon; Jun Hun Kwon; Gun Woo Ha; Bo Kyu Kang; Chul Seung Lee; Hye Kwon Kim; Byeong Yeal Jung; Jae Hong Kim; Jin Sik Oh
Journal:  J Vet Sci       Date:  2009-12       Impact factor: 1.672

5.  A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.

Authors:  Kawsar R Talaat; Ruth A Karron; Karen A Callahan; Catherine J Luke; Susan C DiLorenzo; Grace L Chen; Elaine W Lamirande; Hong Jin; Kathy L Coelingh; Brian R Murphy; George Kemble; Kanta Subbarao
Journal:  Vaccine       Date:  2009-04-17       Impact factor: 3.641

6.  Evaluating surveillance strategies for the early detection of low pathogenicity avian influenza infections.

Authors:  Arianna Comin; Arjan Stegeman; Stefano Marangon; Don Klinkenberg
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

7.  Transmission dynamics of low pathogenicity avian influenza infections in Turkey flocks.

Authors:  Arianna Comin; Don Klinkenberg; Stefano Marangon; Anna Toffan; Arjan Stegeman
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

8.  Evaluation of a Subunit H5 Vaccine and an Inactivated H5N2 Avian Influenza Marker Vaccine in Ducks Challenged with Vietnamese H5N1 Highly Pathogenic Avian Influenza Virus.

Authors:  Tze-Hoong Chua; Connie Y H Leung; H E Fang; Chun-Kin Chow; Siu-Kit Ma; Sin-Fun Sia; Iris H Y Ng; Stanley G Fenwick; Cassandra M James; Sin Bin Chua; Siang Thai Chew; Jimmy Kwang; J S M Peiris; Trevor M Ellis
Journal:  Influenza Res Treat       Date:  2010-06-27

9.  A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection.

Authors:  Sankhiros Babapoor; Tobias Neef; Christian Mittelholzer; Theodore Girshick; Antonio Garmendia; Hongwei Shang; Mazhar I Khan; Peter Burkhard
Journal:  Influenza Res Treat       Date:  2012-01-12

Review 10.  Prevalence and control of H7 avian influenza viruses in birds and humans.

Authors:  E M Abdelwhab; J Veits; T C Mettenleiter
Journal:  Epidemiol Infect       Date:  2014-01-15       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.